The Carlyle Group, Brighton Park Capital and Indegene, the Bangalore-headquartered enterprise healthtech solutions provider, has announced that Carlyle and Brighton Park Capital will acquire minority stakes in the company for US$200 million. The transaction, which is subject to customary regulatory approvals, consists of a secondary sale from existing shareholders of Indegene and a primary investment…